Gender differences in non-ischemic myocardial remodeling: Are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase

Pflugers Archiv European Journal of Physiology

Volumn 465, Issue 5, 2013, Pages 687-697

  Janicki, Joseph S ^a   Spinale, Francis G ^a,b,c   Levick, Scott P ^d  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c WJB Dorn VA Medical Center   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Estrogen modulation; Integrins; Mast cells; Membrane type 1 matrix metalloproteinase; Non ischemic myocardial remodeling

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; INTEGRIN; INTERSTITIAL COLLAGENASE;

EXTRACELLULAR MATRIX; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HEART VOLUME; HORMONAL REGULATION; HUMAN; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; OVARIECTOMY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEX DIFFERENCE;

ANIMALS; ESTROGENS; FEMALE; HUMANS; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 14; MICE; MYOCARDIUM; SEX CHARACTERISTICS; VENTRICULAR REMODELING;

EID: 84878016359     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1229-9     Document Type: Review

References (90)

1. Anversa P, Melissari M, Beghi C, Olivetti G (1984) Structural compensatory mechanisms in rat heart in early spontaneous hypertension. Am J Physiol 246:H739-H746
2. Badenhorst D, Maseko M, Tsotetsi OJ, Naidoo A, Brooksbank R, Norton GR, Woodiwiss AJ (2003) Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc Res 57:632-641
3. Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, Zile MR (2003) Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 284:H122-H132
4. Bhuiyan MS, Shioda N, Fukunaga K (2007) Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am J Physiol Endocrinol Metab 293:E1606-E1614
5. Bobik A (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26:1712-1720
6. Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault G (2004) Alpha8beta1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium. J Mol Cell Cardiol 36:343-353
7. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS (2002) Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol 283:H518-H525
8. Brower GL, Henegar JR, Janicki JS (1996) Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol 271:H2071-H2078
9. Brower GL, Janicki JS (2005) Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Cardiac Fail 11:548-556
10. Brower GL, Gardner JD, Janicki JS (2003) Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 251:89-95
11. Brower GL, Janicki JS (2001) Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol 280:H674-H683
12. Caughey GH, Raymond WW, Wolters PJ (2000) Angiotensin II generation by mast cell α- and β-chymases. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1480:245-257
13. Chan V, Fenning A, Levick SP, Loch D, Chunduri P, Iyer A, Teo YL, Hoey A, Wilson K, Burstow D, Brown L (2011) Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats. J Cardiovasc Pharmacol 57:469-478
14. Chancey AL, Brower GL, Peterson JT, Janicki JS (2002) Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation 105:1983-1988
15. Chancey AL, Gardner JD, Murray DB, Brower GL, Janicki JS (2005) Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. Am J Physiol Heart Circ Physiol 289:H316-H321
16. Collier P, Watson CJ, van Es MH, Phelan D, McGorrian C, Tolan M, Ledwidge MT, McDonald KM, Baugh JA (2012) Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype. J Mol Cell Cardiol 52:148-153
17. Combs AB, Acosta D (1990) Toxic mechanisms of the heart: a review. Toxicol Pathol 18:583-596
18. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751-757
19. Dallas SL, Sivakumar P, Jones CJ, Chen Q, Peters DM, Mosher DF, Humphries MJ, Kielty CM (2005) Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J Biol Chem 280:18871-18880
20. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, Weinberg EO, Bartunek J, Thielen T, Didenko VV, Lorell BH (2000) Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation 101:2854-2862
21. Du Y, Plante E, Janicki JS, Brower GL (2010) Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload. Am J Pathol 177:1155-1163
22. Dubey RK, Gillespie DG, Jackson EK, Keller PJ (1998) 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31:522-528
23. Feng XH, Derynck R (2005) Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659-693
24. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz NP, Kintscher U, Gustafsson JA, Regitz-Zagrosek V (2010) Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 298:R1597-R1606
25. Gardner JD, Murray DB, Voloshenyuk TG, Brower GL, Bradley JM, Janicki JS (2010) Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am J Physiol Heart Circ Physiol 298:H497-H504
26. Gardner JD, Brower GL, Janicki JS (2002) Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 8:101-107
27. Gardner JD, Brower GL, Voloshenyuk TG, Janicki JS (2008) Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circ Physiol 294:H198-H204
28. Ghosh AK (2002) Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med 227:301-314
29. Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF (2003) Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60:608-616
30. Grandi AM, Venco A, Barzizza F, Scalise F, Pantaleo P, Finardi G (1992) Influence of age and sex on left ventricular anatomy and function in normals. Cardiology 81:8-13
31. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, Ramamurthy NS (1989) Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84:1657-1662
32. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A (2002) Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195:375-381
33. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P, Van de WF, Pinto YM, Janssens S (2005) Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 112:1136-1144
34. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Jama 280:605-613
35. Janicki JS, Matsubara BB (1994) Myocardial collagen and left ventricular diastolic dysfunction. In: Gaasch WH, LeWinter MM (eds) Left ventricular diastolic dysfunction. Lea & Febiger, Philadelphia, pp 125-140
36. Janicki JS, Brower GL, Gardner JD, Forman MF, Stewart J, Murray DB, Chancey AL (2006) Cardiac mast cell regulation of matrix metalloproteinase- related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69:657-665
37. Jobe LJ, Melendez GC, Levick SP, Du Y, Brower GL, Janicki JS (2009) TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol 297:H1462-H1468
38. Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A (2012) A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res 95:77-85
39. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J (2001) Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 52:354-362
40. Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 5:571-578
41. Lees M, Taylor DJ, Woolley DE (1994) Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 223:171-177
42. Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL (2009) Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension 53:1041-1047
43. Levick SP, Gardner JD, Holland M, Hauer-Jensen M, Janicki JS, Brower GL (2008) Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats. J Mol Cell Cardiol 45:56-61
44. Li J, Lu H, Plante E, Melendez GC, Levick SP, Janicki JS (2012) Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart. J Mol Cell Cardiol 53:469-474
45. Liu Z, Hilbelink DR, Crockett WB, Gerdes AM (1991) Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res 69:52-58
46. Liu Z, Hilbelink DR, Gerdes AM (1991) Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 2. Long-term effects. Circ Res 69:59-65
47. Lu H, Melendez GC, Levick SP, Janicki JS (2012) Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype. Am J Physiol Heart Circ Physiol 302:H811-H817
48. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz-Zagrosek V (2010) 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res 85:719-728
49. McLarty JL, Melendez GC, Brower GL, Janicki JS, Levick SP (2011) Tryptase/protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 58:264-270
50. Melendez GC, Li J, Law BA, Janicki JS, Supowit SC, Levick SP (2011) Substance P induces adverse myocardial remodeling via a mechanism involving cardiac mast cells. Cardiovasc Res 92:420-429
51. Melendez GC, Voloshenyuk TG, McLarty JL, Levick SP, Brower GL (2010) Oxidative stress mediated cardiac mast cell degranulation. Toxicol Environ Chem 92:1293-1301
52. Murray DB, Gardner JD, Brower GL, Janicki JS (2004) Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287:H2295-H2299
53. Murray DB, Gardner JD, Brower GL, Janicki JS (2008) Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats. Am J Physiol Heart Circ Physiol 294:H1251-H1257
54. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411
55. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ (1997) Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96:1991-1998
56. Panizo A, Mindan FJ, Galindo MF, Cenarruzabeitia E, Hernandez M, Diez J (1995) Are mast cells involved in hypertensive heart disease? J Hypertens 13:1201-1208
57. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER (2010) Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol 24:2152-2165
58. Pelzer T, Neumann M, de Jager T, Jazbutyte V, Neyses L (2001) Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem Biophys Res Commun 286:1153-1157
59. Peterson JT (2001) Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103:2303-2309
60. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M, Dworatzek E, Mahmoodzadeh S, Schubert C, Becher E, Hampl H, Hetzer R (2010) Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 122:S23-S28
61. Qiu Y, Liao R, Zhang X (2009) Intervention of cardiomyocyte death based on the impedance-sensing technique of monitoring cell adhesion. Conf Proc IEEE Eng Med Biol Soc 2009:4457-4460
62. Rifkin DB (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 280:7409-7412
63. Ropero AB, Eghbali M, Minosyan TY, Tang G, Toro L, Stefani E (2006) Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol 41:496-510
64. Ross RS (2002) The extracellular connections: the role of integrins in myocardial remodeling. J Card Fail 8:S326-S331
65. Ross RS, Borg TK (2001) Integrins and the myocardium. Circ Res 88:1112-1119
66. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
67. Ruddy JM, Jones JA, Stroud RE, Mukherjee R, Spinale FG, Ikonomidis JS (2009) Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation 120:S262-S268
68. Salpeter SR, Walsh JM, Greyber E, Ormiston TM, Salpeter EE (2004) Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 19:791-804
69. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, Kober L, Jensen JE (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 345:e6409
70. Seguin CA, Pilliar RM, Madri JA, Kandel RA (2008) TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration. Spine 33:356-365
71. Shiota N, Rysa J, Kovanen PT, Ruskoaha H, Kokkonen JO, Lindstedt KA (2003) A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 21:1823-1825
72. Simon JA (2012) What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone. Climacteric 15(Suppl 1):3-10
73. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, Rockman HA, Korach KS, Murphy E (2005) Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol 288:H469-H476
74. Spinale FG, Coker ML, Krombach SR, Mukherjee R, Hallak H, Houck WV, Clair MJ, Kribbs SB, Johnson LL, Peterson JT, Zile MR (1999) Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 85:364-376
75. Staufer BL, Leinwand LA (2004) Sex differences in cardiac muscle and remodeling. Adv Molec Cell Biol 34:131-145
76. Stewart JA Jr, Cashatt DO, Borck AC, Brown JE, Carver WE (2006) 17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. J Mol Cell Cardiol 41:97-107
77. Stewart JA Jr, Massey EP, Fix C, Zhu J, Goldsmith EC, Carver W (2010) Temporal alterations in cardiac fibroblast function following induction of pressure overload. Cell Tissue Res 340:117-126
78. Tamura T, Said S, Gerdes AM (1999) Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 33:676-680
79. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G (2005) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280:9291-9296
80. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA (2001) 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419-1423
81. Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW (2007) Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 335:239
82. Voloshenyuk TG, Gardner JD (2010) Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. Am J Physiol Regul Integr Comp Physiol 299:R683-R693
83. Wang X, Li F, Gerdes AM (1999) Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: I. Regional hemodynamics and myocyte remodeling. J Mol Cell Cardiol 31:307-317
84. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI (1988) Collegen remodeling of the pressure overloaded, hypertrophied nonhuman primate myocardium. Circ Res 62:757-765
85. Weber KT, Brilla CG, Janicki JS (1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27:341-348
86. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH (1999) Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264-273
87. Yang YN, Wang F, Zhou W, Wu ZQ, Xing YQ (2012) TNF-alpha stimulates MMP-2 and MMP-9 activities in human corneal epithelial cells via the activation of FAK/ERK signaling. Ophthalmic Res 48:165-170
88. Yarbrough WM, Mukherjee R, Stroud RE, Rivers WT, Oelsen JM, Dixon JA, Eckhouse SR, Ikonomidis JS, Zile MR, Spinale FG (2012) Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature. J Thorac Cardiovasc Surg 143:215-223
89. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horiuti T (2007) Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 44:1977-1985
90. Zile MR, Baicu CF, Stroud RE, Van Laer A, Arroyo J, Mukherjee R, Jones JA, Spinale FG (2012) Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis. Am J Physiol Heart Circ Physiol 302:H1429-H1437